HomeInsightsStock Comparison

Bharat Immunological Biological Corporation Ltd vs Concord Biotech Ltd Stock Comparison

Bharat Immunological Biological Corporation Ltd vs Concord Biotech Ltd Stock Comparison

Last Updated on: Aug 08, 2025

Key Highlights

  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 21.8 as of 08 Aug 10:45.
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 51.7 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Concord Biotech Ltd changed from ₹ 15922 crore on March 2024 to ₹ 15922 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Concord Biotech Ltd for the Mar '25 is ₹ 439.27 crore as compare to the Dec '24 revenue of ₹ 260.78 crore. This represent the growth of 68.44%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Concord Biotech Ltd for the Mar '25 is ₹ 198.26 crore as compare to the Dec '24 ebitda of ₹ 114.51 crore. This represent the growth of 73.14%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Concord Biotech Ltd changed from ₹ 54.49 crore to ₹ 140.39 crore over 8 quarters. This represents a CAGR of 60.51% .
  • The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Concord Biotech Ltd changed from 24.05 % on March 2020 to 30.03 % on March 2024 . This represents a CAGR of 4.54% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Concord Biotech Ltd

  • Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
  • Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
  • Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group

Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Fl...

Read more

08 Jan 2025 14:45

News

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartron...

Read more

06 Jan 2025 12:15

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 2024 17:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 2024 10:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 2023 10:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 2023 18:37

Concord Biotech Ltd News Hub

News

Concord Biotech to declare Quarterly Results

Concord Biotech will hold a meeting of the Board of Directors of the Company on 8 August 2...

Read more

04 Aug 2025 12:03

News

Concord Biotech's Dholka unit clears Russian GMP inspection

Concord Biotech announced the successful completion of the Russian GMP (Good Manufacturing...

Read more

26 Jul 2025 10:02

News

Concord Biotech acquires 75% stake in Stellon Biotech

Concord Biotech has made an equity investment of USD 1,500 in Stellon Biotech Inc. This in...

Read more

02 Jul 2025 12:10

News

Concord Biotech edges higher on value buying; trades above 100-day SMA

The scrip had declined 15.63% in seven sessions to end at Rs 1,780.75 yesterday, from its ...

Read more

25 Jun 2025 11:40

News

Concord Biotech's API facility completes USFDA inspection

Concord Biotech has received an Establishment Inspection Report (EIR) from the US Food and...

Read more

24 Jun 2025 19:06

News

Board of Concord Biotech recommends final dividend

Concord Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

30 May 2025 11:14

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Concord Biotech Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Concord Biotech Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 93 Cr while Market cap of Concord Biotech Ltd is 17,084 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Concord Biotech Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Concord Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Concord Biotech Ltd?

As of August 8, 2025, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹21.63. On the other hand, Concord Biotech Ltd stock price is INR ₹1633.1.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Concord Biotech Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Concord Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions